RecruitingNot ApplicableNCT06918119

Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida

Characterization of Transcutaneous Spinal Cord Stimulation for Enabling Reflex Motor Evoked Responses in Children and Youth With Spina Bifida


Sponsor

Mayo Clinic

Enrollment

30 participants

Start Date

Aug 7, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

A study to use transcutaneous spinal cord stimulation to characterize sensorimotor deficits in a pediatric population of individuals with spina bifida.


Eligibility

Min Age: 5 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Transcutaneous stimulation for people with myelomeningocele and spina bifida. The study is currently recruiting participants at 1 location. People eligible for this study include aged 5 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscutaneous stimulation

DS8R (Digitimer LLC) for transcutaneous neurostimulation.


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06918119


Related Trials